13F filer · CIK 315066 ↗
Fidelity Investments
You are looking at Q3 2024. See the latest, Q2 2026 →
Reported value
$1.64T
+5.2% on the quarter before
Positions
5,487
519 new · 394 sold out
Top 10
34.4%
of the value
Est. gain
+$69.95B
on stocks held all quarter
Est. return
+4.7%
on those stocks since Q2 2024
Positions as of Sep 30, 2024, from Fidelity Investments's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 44% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2024. Striped tiles are options.
Largest buys
Since Q2 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Apple~$4.25BAdded · 4.7% → 5.2%+18,224,005 shares
- Ferguson Enterprises Inc~$1.67BNew · 0.0% → 0.1%+8,468,003 shares
- Gilead Sciences Inc~$1.23BAdded · 0.1% → 0.2%+14,680,161 shares
- Fidelity Merrimack Str Tr~$1.10BAdded · 0.0% → 0.1%+24,782,532 shares
- Carvana Co~$1.02BAdded · 0.1% → 0.1%+5,882,656 shares
- Hca Healthcare Inc~$974.6MAdded · 0.0% → 0.1%+2,397,883 shares
- Royal Bk Cda~$961.3MAdded · 0.1% → 0.1%+7,702,585 shares
- Alphabet~$945.5MAdded · 1.3% → 1.2%+5,655,022 shares
- Visa Inc.~$897.9MAdded · 0.9% → 1.0%+3,265,518 shares
- Danaher Corporation~$894.6MAdded · 0.3% → 0.4%+3,217,631 shares
Largest sells
Since Q2 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Nvidia~$5.61BCut · 8.3% → 7.4%−46,189,661 shares
- Microsoft~$2.18BCut · 6.2% → 5.5%−5,056,730 shares
- Lululemon Athletica Inc~$1.96BCut · 0.3% → 0.2%−7,213,943 shares
- Eaton Corp Plc~$1.67BCut · 0.4% → 0.3%−5,032,549 shares
- Asml Holding N V~$1.60BCut · 0.4% → 0.2%−1,923,351 shares
- Ferguson Plc New~$1.58BSold out · 0.1% → 0.0%−8,179,068 shares
- Sea~$1.29BCut · 0.1% → 0.1%−13,718,726 shares
- Micron~$1.21BCut · 0.4% → 0.2%−11,674,716 shares
- Vertiv~$1.16BCut · 0.1% → 0.1%−11,669,655 shares
- Salesforce~$1.14BCut · 0.5% → 0.4%−4,181,223 shares
Holdings
As of Sep 30, 2024. Changes are in shares against Jun 30, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NvidiaCOM · shares −4.4% · price −1.7% | 7.4% | $121.16B | −$2.10B | ||||||||
| MicrosoftCOM · shares −2.3% · price −3.7% | 5.5% | $91.06B | −$3.52B | ||||||||
| AppleCOM · shares +5.3% · price +10.6% | 5.2% | $84.78B | +$7.74B | ||||||||
| MetaCL A · shares −0.1% · price +13.5% | 4.8% | $79.15B | +$9.43B | ||||||||
| AmazonCOM · shares −0.8% · price −3.6% | 3.7% | $60.88B | −$2.26B | ||||||||
| AlphabetCAP STK CL A · shares −0.9% · price −8.9% | 2.3% | $37.53B | −$3.69B | ||||||||
| Eli LillyCOM · shares −1.3% · price −2.1% | 1.8% | $29.27B | −$642.2M | ||||||||
| Berkshire Hathaway Inc DelCL A · shares +0.1% · price +12.9% | 1.4% | $23.13B | +$2.64B | ||||||||
| AlphabetCAP STK CL C · shares +5.2% · price −8.8% | 1.2% | $19.19B | −$1.77B | ||||||||
| Unitedhealth Group IncCOM · shares −0.6% · price +14.8% | 1.2% | $19.00B | +$2.45B | ||||||||
| Exxon Mobil CorpCOM · shares +0.3% · price +1.8% | 1.1% | $17.80B | +$318.1M | ||||||||
| Visa Inc.COM CL A · shares +6.1% · price +4.8% | 0.96% | $15.70B | +$672.0M | ||||||||
| BroadcomCOM · shares +1.8% · price +28.9% | 0.95% | $15.59B | +$3.44B | ||||||||
| NetflixCOM · shares −3.4% · price +5.1% | 0.89% | $14.55B | +$705.4M | ||||||||
| Ge AerospaceCOM NEW · shares −2.7% · price +18.6% | 0.76% | $12.42B | +$1.95B | ||||||||
| Boston Scientific CorpCOM · shares −4.4% · price +8.8% | 0.69% | $11.33B | +$918.0M | ||||||||
| Wells Fargo Co NewCOM · shares +3.6% · price −4.9% | 0.67% | $11.07B | −$548.3M | ||||||||
| Regeneron PharmaceuticalsCOM · shares −2.7% · price +0.0% | 0.66% | $10.89B | +$2.2M | ||||||||
| MastercardCL A · shares +3.4% · price +11.9% | 0.64% | $10.55B | +$1.09B | ||||||||
| Jpmorgan Chase & Co.COM · shares −9.0% · price +4.3% | 0.62% | $10.19B | +$415.6M | ||||||||
| TSMCSPONSORED ADS · shares +7.2% · price −0.1% | 0.59% | $9.72B | −$7.3M | ||||||||
| Marvell Technology IncCOM · shares +0.2% · price +3.2% | 0.57% | $9.38B | +$288.3M | ||||||||
| Costco Whsl Corp NewCOM · shares +3.6% · price +4.3% | 0.50% | $8.25B | +$328.2M | ||||||||
| Bank America CorpCOM · shares −4.8% · price −0.2% | 0.46% | $7.56B | −$17.2M | ||||||||
| UberCOM · shares −6.2% · price +3.4% | 0.45% | $7.35B | +$242.7M | ||||||||
| Total · 5,487 positions | 100% | $1.64T | +$69.95B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2024 to Q3 2024: 4,815 stocks held throughout, up $69.95B (+4.7%).
- Meta+$9.43B+14%
- Apple+$7.74B+11%
- Broadcom12:1 split+$3.44B+29%
- Berkshire Hathaway Inc Del+$2.64B+13%
- Unitedhealth Group Inc+$2.45B+15%
- Alphabet−$1.77B−9%
- Nvidia−$2.10B−2%
- Amazon−$2.26B−4%
- Microsoft−$3.52B−4%
- Alphabet−$3.69B−9%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 10 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $2.30T+21% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.90T−3% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $1.96T+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $1.92T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $1.77T+13% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.57T−7% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $1.68T+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $1.64T+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $1.56T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.49T+14% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.30T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.16T−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $1.19T−45% | SEC ↗ |
| Q1 2023 | May 11, 2023 (amended) | $2.19T+117% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $1.01T+5% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $958.93B−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $1.00T−20% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $1.25T−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $1.35T+7% | SEC ↗ |
| Q3 2021 | Feb 14, 2022 (amended) | $1.26T−1% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $1.28T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $1.17T+4% | SEC ↗ |
| Q4 2020 | Feb 8, 2021 | $1.12T+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $989.33B+9% | SEC ↗ |
| Q2 2020 | Aug 24, 2020 (amended) | $909.48B+26% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $722.13B−20% | SEC ↗ |
| Q4 2019 | Feb 7, 2020 | $906.40B+9% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $833.77B−3% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $856.19B+3% | SEC ↗ |
| Q1 2019 | May 13, 2019 (amended) | $834.93B+14% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $730.25B−18% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $888.88B+2% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 (amended) | $868.68B+3% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $842.35B−1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $853.06B+3% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $827.12B+3% | SEC ↗ |
| Q2 2017 | Aug 29, 2017 (amended) | $804.55B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $787.10B+5% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 (amended) | $748.25B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $750.86B+2% | SEC ↗ |
| Q2 2016 | Aug 11, 2016 | $732.58B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $722.80B | SEC ↗ |